Industry Growth Insights published a new data on “Zafirlukast Market”. The research report is titled “Zafirlukast Market research by Types (Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027, 10 mg, 20 mg), By Applications (Leukotriene Antagonist, Treatment of Asthma), By Players/Companies Target Molecule Corp., Merck, Cayman Chemical Company, APExBIO Technology LLC, Carbosynth Ltd, Biorbyt, Toronto Research Chemicals, Glr Innovations, Medical Isotopes, Inc., AvaChem Scientific, Tokyo Chemical Industry Co.,Ltd., Carbone scientific, Santa Cruz Biotechnology, Inc., Chemos GmbH and Co. KG, 3B Scientific, MedChemExpress LLC, AK Scientific, Inc., CarboMer, Inc., Creative Enzymes, Combi-Blocks, Chromo Laboratories India Pvt Ltd, Dr.Reddy's Laboratories Limited, Shanghai Beilang Biotechnology Co., Ltd, Shanghai Yuanye Bio-Technology Co., Ltd, Shanghai Acmec Biochemical Co.,Ltd, Shanghai McLin Biochemical Technology Co., Ltd, Dalian Meilun Biotechnology Co., Ltd, BOC Sciences, Standardpharm Co., Ltd., Aibixin (Shanghai) Biotechnology Co., Ltd, Glpbio, Abmole Bioscience Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Zafirlukast Market Research Report
By Type
Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027, 10 mg, 20 mg
By Application
Leukotriene Antagonist, Treatment of Asthma
By Companies
Target Molecule Corp., Merck, Cayman Chemical Company, APExBIO Technology LLC, Carbosynth Ltd, Biorbyt, Toronto Research Chemicals, Glr Innovations, Medical Isotopes, Inc., AvaChem Scientific, Tokyo Chemical Industry Co.,Ltd., Carbone scientific, Santa Cruz Biotechnology, Inc., Chemos GmbH and Co. KG, 3B Scientific, MedChemExpress LLC, AK Scientific, Inc., CarboMer, Inc., Creative Enzymes, Combi-Blocks, Chromo Laboratories India Pvt Ltd, Dr.Reddy's Laboratories Limited, Shanghai Beilang Biotechnology Co., Ltd, Shanghai Yuanye Bio-Technology Co., Ltd, Shanghai Acmec Biochemical Co.,Ltd, Shanghai McLin Biochemical Technology Co., Ltd, Dalian Meilun Biotechnology Co., Ltd, BOC Sciences, Standardpharm Co., Ltd., Aibixin (Shanghai) Biotechnology Co., Ltd, Glpbio, Abmole Bioscience Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Zafirlukast Market Report Segments:
The global Zafirlukast market is segmented on the basis of:
Types
Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027, 10 mg, 20 mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Leukotriene Antagonist, Treatment of Asthma
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Target Molecule Corp.
- Merck
- Cayman Chemical Company
- APExBIO Technology LLC
- Carbosynth Ltd
- Biorbyt
- Toronto Research Chemicals
- Glr Innovations
- Medical Isotopes, Inc.
- AvaChem Scientific
- Tokyo Chemical Industry Co.,Ltd.
- Carbone scientific
- Santa Cruz Biotechnology, Inc.
- Chemos GmbH and Co. KG
- 3B Scientific
- MedChemExpress LLC
- AK Scientific, Inc.
- CarboMer, Inc.
- Creative Enzymes
- Combi-Blocks
- Chromo Laboratories India Pvt Ltd
- Dr.Reddy's Laboratories Limited
- Shanghai Beilang Biotechnology Co., Ltd
- Shanghai Yuanye Bio-Technology Co., Ltd
- Shanghai Acmec Biochemical Co.,Ltd
- Shanghai McLin Biochemical Technology Co., Ltd
- Dalian Meilun Biotechnology Co., Ltd
- BOC Sciences
- Standardpharm Co., Ltd.
- Aibixin (Shanghai) Biotechnology Co., Ltd
- Glpbio
- Abmole Bioscience Inc.
Highlights of The Zafirlukast Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027
- 10 mg
- 20 mg
- By Application:
- Leukotriene Antagonist
- Treatment of Asthma
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zafirlukast Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zafirlukast is a medication used to treat asthma. It works by reducing the amount of air that is breathed in, and it can be taken either orally (by mouth) or as an inhaler.
Some of the major companies in the zafirlukast market are Target Molecule Corp., Merck, Cayman Chemical Company, APExBIO Technology LLC, Carbosynth Ltd, Biorbyt, Toronto Research Chemicals, Glr Innovations, Medical Isotopes, Inc., AvaChem Scientific, Tokyo Chemical Industry Co.,Ltd., Carbone scientific, Santa Cruz Biotechnology, Inc., Chemos GmbH and Co. KG, 3B Scientific, MedChemExpress LLC, AK Scientific, Inc., CarboMer, Inc., Creative Enzymes, Combi-Blocks, Chromo Laboratories India Pvt Ltd, Dr.Reddy's Laboratories Limited, Shanghai Beilang Biotechnology Co., Ltd, Shanghai Yuanye Bio-Technology Co., Ltd, Shanghai Acmec Biochemical Co.,Ltd, Shanghai McLin Biochemical Technology Co., Ltd, Dalian Meilun Biotechnology Co., Ltd, BOC Sciences, Standardpharm Co., Ltd., Aibixin (Shanghai) Biotechnology Co., Ltd, Glpbio, Abmole Bioscience Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Zafirlukast Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Zafirlukast Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Zafirlukast Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Zafirlukast Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Zafirlukast Market Size & Forecast, 2018-2028 4.5.1 Zafirlukast Market Size and Y-o-Y Growth 4.5.2 Zafirlukast Market Absolute $ Opportunity
Chapter 5 Global Zafirlukast Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Zafirlukast Market Size Forecast by Type
5.2.1 Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027
5.2.2 10 mg
5.2.3 20 mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Zafirlukast Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Zafirlukast Market Size Forecast by Applications
6.2.1 Leukotriene Antagonist
6.2.2 Treatment of Asthma
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Zafirlukast Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Zafirlukast Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Zafirlukast Analysis and Forecast
9.1 Introduction
9.2 North America Zafirlukast Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Zafirlukast Market Size Forecast by Type
9.6.1 Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027
9.6.2 10 mg
9.6.3 20 mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Zafirlukast Market Size Forecast by Applications
9.10.1 Leukotriene Antagonist
9.10.2 Treatment of Asthma
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Zafirlukast Analysis and Forecast
10.1 Introduction
10.2 Europe Zafirlukast Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Zafirlukast Market Size Forecast by Type
10.6.1 Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027
10.6.2 10 mg
10.6.3 20 mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Zafirlukast Market Size Forecast by Applications
10.10.1 Leukotriene Antagonist
10.10.2 Treatment of Asthma
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Zafirlukast Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Zafirlukast Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Zafirlukast Market Size Forecast by Type
11.6.1 Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027
11.6.2 10 mg
11.6.3 20 mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Zafirlukast Market Size Forecast by Applications
11.10.1 Leukotriene Antagonist
11.10.2 Treatment of Asthma
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Zafirlukast Analysis and Forecast
12.1 Introduction
12.2 Latin America Zafirlukast Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Zafirlukast Market Size Forecast by Type
12.6.1 Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027
12.6.2 10 mg
12.6.3 20 mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Zafirlukast Market Size Forecast by Applications
12.10.1 Leukotriene Antagonist
12.10.2 Treatment of Asthma
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Zafirlukast Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Zafirlukast Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Zafirlukast Market Size Forecast by Type
13.6.1 Global Zafirlukast Market Size Growth Rate by Drug Specifications: 2016 VS 2021 VS 2027
13.6.2 10 mg
13.6.3 20 mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Zafirlukast Market Size Forecast by Applications
13.10.1 Leukotriene Antagonist
13.10.2 Treatment of Asthma
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Zafirlukast Market: Competitive Dashboard
14.2 Global Zafirlukast Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Target Molecule Corp.
14.3.2 Merck
14.3.3 Cayman Chemical Company
14.3.4 APExBIO Technology LLC
14.3.5 Carbosynth Ltd
14.3.6 Biorbyt
14.3.7 Toronto Research Chemicals
14.3.8 Glr Innovations
14.3.9 Medical Isotopes, Inc.
14.3.10 AvaChem Scientific
14.3.11 Tokyo Chemical Industry Co.,Ltd.
14.3.12 Carbone scientific
14.3.13 Santa Cruz Biotechnology, Inc.
14.3.14 Chemos GmbH and Co. KG
14.3.15 3B Scientific
14.3.16 MedChemExpress LLC
14.3.17 AK Scientific, Inc.
14.3.18 CarboMer, Inc.
14.3.19 Creative Enzymes
14.3.20 Combi-Blocks
14.3.21 Chromo Laboratories India Pvt Ltd
14.3.22 Dr.Reddy's Laboratories Limited
14.3.23 Shanghai Beilang Biotechnology Co., Ltd
14.3.24 Shanghai Yuanye Bio-Technology Co., Ltd
14.3.25 Shanghai Acmec Biochemical Co.,Ltd
14.3.26 Shanghai McLin Biochemical Technology Co., Ltd
14.3.27 Dalian Meilun Biotechnology Co., Ltd
14.3.28 BOC Sciences
14.3.29 Standardpharm Co., Ltd.
14.3.30 Aibixin (Shanghai) Biotechnology Co., Ltd
14.3.31 Glpbio
14.3.32 Abmole Bioscience Inc.